Clinical Trials Logo

Orthopedic Surgery clinical trials

View clinical trials related to Orthopedic Surgery.

Filter by:

NCT ID: NCT00702416 Completed - Nerve Block Clinical Trials

Ultrasound Guidance for Interscalene Brachial Plexus Block

Start date: May 2008
Phase: Phase 4
Study type: Interventional

This study has been designed to assess the possible advantages of using ultrasound imaging to block the brachial plexus (i.e., nerves of the upper limb) in patients undergoing shoulder surgery. The ultrasound technique will be compared with the current gold standard, electrical nerve stimulation. The aim of this study is to define which technique is better in terms of time to onset of anesthesia.

NCT ID: NCT00293631 Completed - Orthopedic Surgery Clinical Trials

Study of Lornoxicam or Ketorolac or Placebo for Post-Operative Pain After Bunionectomy

Start date: November 2005
Phase: Phase 2
Study type: Interventional

To determine whether a single dose of intravenous lornoxicam is superior to intravenous placebo for management of post-operative pain in patients who have surgical removal of a bunion on the lower extremity. One-fourth of patients in this study will receive a single dose of intravenous ketorolac for management of pain and one-fourth of patients in this study will receive a single dose of an intravenous placebo.

NCT ID: NCT00270075 Completed - Blood Transfusion Clinical Trials

A Study to Determine the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Not Anemic and Who Will be Undergoing Orthopedic or Heart and Blood Vessel Surgery

Start date: January 1990
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to determine whether epoetin alfa will enable self-donation of at least 4 units of blood during the 2-week period before surgery (which is a shorter period of time than the conventional 3-week blood donation period before surgery) in patients who are not anemic and who will be undergoing orthopedic or heart and blood vessel surgery. Epoetin alfa is a genetically engineered protein that stimulates red blood cell production.

NCT ID: NCT00270023 Completed - Blood Transfusion Clinical Trials

A Study to Determine the Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Non-anemic Patients Who Are Undergoing Orthopedic, Heart and Blood Vessel, or Breast Reduction Surgery; Performed in Combination With a Procedure to Reduce Blood Loss During Surgery.

Start date: n/a
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to determine the safety and effectiveness of epoetin alfa and whether epoetin alfa will enable self-donation of blood during an 11-day period before surgery (which is shorter than the conventional 3-week blood donation period before surgery) in patients who are not anemic and who will be undergoing orthopedic, heart and blood vessel, or breast reduction surgery. Epoetin alfa is a genetically engineered protein that stimulates red blood cell production. Normovolemic hemodilution (NVHD, withdrawal of a patient's blood immediately before surgery, immediate replacement of blood with an equal volume of fluid, and return of the withdrawn blood after completion of surgery; a procedure which reduces the loss of blood during surgery) will also be performed.

NCT ID: NCT00192894 Completed - Orthopedic Surgery Clinical Trials

New Methods to Detect a Decrease in Heart Function

Start date: May 2004
Phase: Phase 4
Study type: Observational

The purpose of this study was to evaluate the changes in heart function during onset of spinal anesthesia using a new and less invasive method, the LidcoTMplus.